Viral rebound and safety of nirmatrelvir/ritonavir for lung-transplant recipients infected with SARS-CoV-2

Viral rebound and safety of nirmatrelvir/ritonavir for lung-transplant recipients infected with SARS-CoV-2

Data on the viral rebound and safety of nirmatrelvir/ritonavir in lung transplant (LTx) recipients are limited. The study prospectively followed four LTx recipients. Clinical characteristics, viral RNA dynamic in throat swabs, and tacrolimus blood concentration were monitored regularly. All four LTx...

Full description

Bibliographic Details
Main Authors: Hui Li, Li Zhao, Ke Huang, Xiaoxing Wang, Fei Zhou, Yiming Feng, Liang Ma, Bin Cao, Wenhui Chen
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Biosafety and Health
Subjects:
SARS-CoV-2
Lung transplantation
Nirmatrelvir/ritonavir
Online Access:http://www.sciencedirect.com/science/article/pii/S2590053623001064

Internet

http://www.sciencedirect.com/science/article/pii/S2590053623001064

Similar Items